333 related articles for article (PubMed ID: 27109101)
1. MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.
Shah MY; Martinez-Garcia E; Phillip JM; Chambliss AB; Popovic R; Ezponda T; Small EC; Will C; Phillip MP; Neri P; Bahlis NJ; Wirtz D; Licht JD
Oncogene; 2016 Nov; 35(45):5905-5915. PubMed ID: 27109101
[TBL] [Abstract][Full Text] [Related]
2. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
[TBL] [Abstract][Full Text] [Related]
3. H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres.
de Krijger I; van der Torre J; Peuscher MH; Eder M; Jacobs JJL
Oncogene; 2020 Jun; 39(25):4814-4827. PubMed ID: 32472076
[TBL] [Abstract][Full Text] [Related]
4. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
[TBL] [Abstract][Full Text] [Related]
5. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.
Pei H; Zhang L; Luo K; Qin Y; Chesi M; Fei F; Bergsagel PL; Wang L; You Z; Lou Z
Nature; 2011 Feb; 470(7332):124-8. PubMed ID: 21293379
[TBL] [Abstract][Full Text] [Related]
6. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
[TBL] [Abstract][Full Text] [Related]
7. MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
Min DJ; Ezponda T; Kim MK; Will CM; Martinez-Garcia E; Popovic R; Basrur V; Elenitoba-Johnson KS; Licht JD
Leukemia; 2013 Mar; 27(3):686-94. PubMed ID: 22972034
[TBL] [Abstract][Full Text] [Related]
8. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.
Marango J; Shimoyama M; Nishio H; Meyer JA; Min DJ; Sirulnik A; Martinez-Martinez Y; Chesi M; Bergsagel PL; Zhou MM; Waxman S; Leibovitch BA; Walsh MJ; Licht JD
Blood; 2008 Mar; 111(6):3145-54. PubMed ID: 18156491
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase MMSET promotes AID-mediated DNA breaks at the donor switch region during class switch recombination.
Nguyen HV; Dong J; Panchakshari RA; Kumar V; Alt FW; Bories JC
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10560-E10567. PubMed ID: 29158395
[TBL] [Abstract][Full Text] [Related]
10. Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair.
Hsiao KY; Mizzen CA
J Mol Cell Biol; 2013 Jun; 5(3):157-65. PubMed ID: 23329852
[TBL] [Abstract][Full Text] [Related]
11. PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage.
Zhang J; Lee YR; Dang F; Gan W; Menon AV; Katon JM; Hsu CH; Asara JM; Tibarewal P; Leslie NR; Shi Y; Pandolfi PP; Wei W
Cancer Discov; 2019 Sep; 9(9):1306-1323. PubMed ID: 31217297
[TBL] [Abstract][Full Text] [Related]
12. DICER- and MMSET-catalyzed H4K20me2 recruits the nucleotide excision repair factor XPA to DNA damage sites.
Chitale S; Richly H
J Cell Biol; 2018 Feb; 217(2):527-540. PubMed ID: 29233865
[TBL] [Abstract][Full Text] [Related]
13. Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells.
White-Al Habeeb NM; Garcia J; Fleshner N; Bapat B
Prostate; 2016 Dec; 76(16):1507-1518. PubMed ID: 27404348
[TBL] [Abstract][Full Text] [Related]
14. MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.
Brito JL; Walker B; Jenner M; Dickens NJ; Brown NJ; Ross FM; Avramidou A; Irving JA; Gonzalez D; Davies FE; Morgan GJ
Haematologica; 2009 Jan; 94(1):78-86. PubMed ID: 19059936
[TBL] [Abstract][Full Text] [Related]
15. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Kuo AJ; Cheung P; Chen K; Zee BM; Kioi M; Lauring J; Xi Y; Park BH; Shi X; Garcia BA; Li W; Gozani O
Mol Cell; 2011 Nov; 44(4):609-20. PubMed ID: 22099308
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
[TBL] [Abstract][Full Text] [Related]
17. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
Yang P; Guo L; Duan ZJ; Tepper CG; Xue L; Chen X; Kung HJ; Gao AC; Zou JX; Chen HW
Mol Cell Biol; 2012 Aug; 32(15):3121-31. PubMed ID: 22645312
[TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Hudlebusch HR; Santoni-Rugiu E; Simon R; Ralfkiær E; Rossing HH; Johansen JV; Jørgensen M; Sauter G; Helin K
Clin Cancer Res; 2011 May; 17(9):2919-33. PubMed ID: 21385930
[TBL] [Abstract][Full Text] [Related]
19. The histone methyltransferase MMSET regulates class switch recombination.
Pei H; Wu X; Liu T; Yu K; Jelinek DF; Lou Z
J Immunol; 2013 Jan; 190(2):756-63. PubMed ID: 23241889
[TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]